Company news

Dong-A ST Co., Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies

August 19, 2025

Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA®, receives approval from US FDA

October 14, 2024

Dong-A ST Out License NESP® Biosimilar DA-3880 to Polifarma of Türkiye

November 9, 2022

Decks